Paper Details
- Home
- Paper Details
Barriers and Facilitators to Oral PrEP Use Among Transgender Women in New York City.
Author: BocktingWalter, Carballo-DiéguezAlex, D'AquilaRichard T, FooterKatherine H A, GiguereRebecca, GreeneGeorge J, MacCrateCaitlin, MartinezMichelle, MellmanWill, RaelChristine Tagliaferri, ShermanSusan, ValentePablo
Original Abstract of the Article :
Transgender women may face a disparate risk for HIV/AIDS compared to other groups. In 2012, Truvada was approved for daily use as HIV pre-exposure prophylaxis (PrEP). However, there is a dearth of research about barriers and facilitators to PrEP in transgender women. This paper will shed light on tr...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://pubmed.ncbi.nlm.nih.gov/29589137
データ提供：米国国立医学図書館（NLM）
Barriers and Facilitators to Oral PrEP Use Among Transgender Women in New York City
This study investigates the barriers and facilitators to oral pre-exposure prophylaxis (PrEP) use among transgender women in New York City. The study used four focus groups with 18 transgender women to explore their perceptions and experiences with PrEP. The study found that transgender women identified several barriers to PrEP use, including uncomfortable side effects, difficulty taking pills, stigma, exclusion from advertising campaigns, and lack of research specifically on transgender women and PrEP. The study also identified facilitators to PrEP use, such as reducing pill size, increasing the types of available HIV prevention products, and conducting more research on PrEP in transgender women.
Understanding the Barriers and Facilitators to PrEP Use in Transgender Women
This research sheds light on the unique challenges faced by transgender women in accessing and utilizing PrEP. The study’s findings highlight the need for targeted interventions to address these barriers and promote PrEP use among this vulnerable population. The study's findings highlight the importance of developing tailored interventions that address the specific concerns and needs of transgender women.
Promoting PrEP Access and Use in Transgender Women
This study emphasizes the importance of addressing the unique barriers faced by transgender women in accessing and utilizing PrEP. The study’s findings highlight the need for targeted interventions to address these barriers and promote PrEP use among this vulnerable population. The study’s findings underscore the need for continued research on PrEP in transgender women, tailored advertising campaigns, and increased access to diverse HIV prevention products.
Dr.Camel's Conclusion
This study shines a light on the challenges faced by transgender women in accessing and utilizing PrEP. The findings underscore the need for tailored interventions to address these barriers and promote PrEP use among this vulnerable population. It’s a call to action to create a more inclusive and supportive environment for transgender women in the fight against HIV.
Date :
- Date Completed 2018-11-26
- Date Revised 2019-02-01
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.